Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
114 trends tracked about this subject — the full history, oldest to newest below.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies indicate that early treatment of depression may improve cancer survival rates and lower mortality risks.
Researchers have unveiled an epigenetic blueprint that explains how the 'undruggable' MYC gene drives aggressive cancer amplification.
A radical new pancreatic cancer trial involving daraxonrasib raises hopes across health coverage.
Genmab releases new phase 2 data for its antibody-drug conjugate, prompting claims of superiority over rival treatments.
The oncology community is facing critical questions as divergent trial results emerge regarding the efficacy and scale of cancer vaccines.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research indicates that approximately 1 in 8 cancer cases worldwide are tied to infections, highlighting the critical role of preventative vaccines.
Grail faces lingering reimbursement hurdles despite approaching a landmark FDA approval for its Galleri cancer blood test.
Recent studies show a simple urine test analyzing cell-free RNA can detect bladder cancer and track treatment.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent scientific studies reveal distinct gut microbiome patterns linked to five cancer groups and early-onset cancers.
Recent coverage highlights new artificial intelligence tools enabling women to assess their breast cancer risk.
Recent coverage examines how scientists cracked the RAS mutation in pancreatic cancer and explores Arizona connections to the breakthrough treatment.
A multi-cancer early detection blood test draws investor enthusiasm and trial data coverage across major financial and health outlets.
Recent coverage details a major milestone in pancreatic cancer treatment with the approval of daraxonrasib and new laboratory breakthroughs.
New developments in personalized mRNA cancer vaccines show promise for melanoma and breast cancer, though hurdles in public perception remain.
A new IARC study reveals that five specific infections are responsible for over 2 million new cancer cases annually, accounting for nearly one in eight worldwide.
Advances in personalized mRNA vaccines are showing promise in treating melanoma, though experts warn that misinformation may hinder their adoption.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A major new study reveals that one in eight cancer cases worldwide are linked to common infections.
Recent findings show five-treatment radiotherapy matches surgery and conventional radiation for prostate cancer.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines the intersection of artificial intelligence and cancer research, raising questions about progress and expectations.
14 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research reveals how chronic type II interferon can inadvertently promote tumor growth via mitochondrial RNA and prostaglandin synthesis.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A newly reported protein-based MRI agent achieves earlier detection of lung cancer and hidden metastases without radiation.
Recent scientific coverage details how tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species.
A newly highlighted global analysis links exposure to a common stomach bacterium with a significant share of bowel cancer cases worldwide.
Mass General Brigham Health Plan has removed Dana-Farber from its Medicare Advantage network, leaving cancer patients facing disrupted care.
Researchers have identified bacteria capable of producing testosterone near the prostate, raising new questions regarding its role in cancer development.
A breakthrough pancreatic cancer drug called daraxonrasib has marked a major advance in care, though access remains a challenge.
New research reveals that tumors may weaponize antioxidant proteins to disable the reactive oxygen species T cells need to destroy cancer.
Artificial intelligence is driving a potential 'golden age' in medicine through personalized cancer treatments and streamlined oncology care.
New clinical evidence suggests supervised exercise programs can mitigate the side effects of prostate cancer treatments and improve patient quality of life.
Global health initiatives and medical experts are urging increased prostate cancer screenings to improve early detection and survival rates.
Personalized mRNA cancer vaccines are gaining momentum following Phase III success in melanoma and expanded global clinical trials.
Researchers have identified a potential weak spot in glioblastoma, one of the deadliest forms of brain cancer, by targeting calcium and SET EIP.
Researchers have discovered that a compound found in magic mushrooms may block severe chemotherapy-induced pain in mice.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The FDA approval of a landmark pancreatic cancer drug costing $480,000 annually signals a shifting economic landscape for oncology treatments.
Recent studies reveal alcohol-related cancer deaths have doubled since 1990, with risks tied to just one drink daily.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent FDA approval of daraxonrasib for metastatic pancreatic cancer brings new hope to patients and clinicians alike.
New research suggests that consuming just one alcoholic drink per day may increase the risk of death from various types of cancer.
Health outlets and regional news outlets are highlighting prostate cancer screenings as cases rise.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies point to cancer drugs, BRAF targets, and brain mechanisms as potential new avenues for treating chronic nerve pain.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Researchers at the National University of Singapore have identified a drug capable of disabling a 'master switch' linked to aggressive breast cancer.
Moderna and Merck have reported a significant triumph regarding a collaborative cancer vaccine trial that could revolutionize oncology treatment.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.